Trial NCT02729961

View at ClinicalTrials.gov 
Org. Study IDs: 9522
Secondary IDs: 9522 NCI-2016-00396 P30CA015704

Last trial update was posted on 2019-10-10

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Brentuximab Vedotin Ceritinib Immunoconjugates Immunoglobulins

MeSH Conditions

Lymphoma Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin

Other Conditions

Anaplastic Large Cell Lymphoma, ALK-Positive CD30-Positive Neoplastic Cells Present Systemic Anaplastic Large Cell Lymphoma

Stopping Reasons

Administrative closure

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID